Leukemia, Hairy CellLeukemia, Plasma CellLeukemiaLeukemia, Myeloid, AcuteRadiation DosageRadiation, IonizingLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidRadiation InjuriesCladribineLeukemia, T-CellLeukemia, ExperimentalDose-Response Relationship, RadiationRadiation ToleranceLeukemia, Mast-CellRadiationPentostatinLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHuman T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-CellRadiation ProtectionLeukemia, B-CellRadiation MonitoringLeukemia Virus, MurinePrecursor Cell Lymphoblastic Leukemia-LymphomaGene Products, taxMyeloid Cell Leukemia Sequence 1 ProteinDeltaretrovirus InfectionsDeltaretrovirusLeukemia, Monocytic, AcuteLeukemia, Radiation-InducedRadiation OncologyBone MarrowMoloney murine leukemia virusGene Expression Regulation, LeukemicLeukemia L1210Leukemia Virus, BovineCosmic RadiationLeukemia Virus, FelineAntineoplastic AgentsRadiation Injuries, ExperimentalRemission InductionNeoplasms, Radiation-InducedHTLV-I InfectionsRadiation PneumonitisCombined Modality TherapyGamma RaysTumor Cells, CulturedCell LineLymphomaRadiotherapyT-LymphocytesBackground RadiationMyeloid-Lymphoid Leukemia ProteinImmunophenotypingSplenectomyB-LymphocytesLeukemia, ProlymphocyticMolecular Sequence DataApoptosisLeukemic InfiltrationLeukemia P388Base SequenceLeukemia, Biphenotypic, AcutePrecursor B-Cell Lymphoblastic Leukemia-LymphomaRadiotherapy DosageRadiometryKaryotypingFlow CytometryUltraviolet RaysAntibodies, MonoclonalAcute DiseaseFriend murine leukemia virusCoformycinTreatment OutcomeRadiation EffectsNeoplasm ProteinsAntineoplastic Combined Chemotherapy ProtocolsChromosome AberrationsHL-60 CellsCell Line, TumorCytarabineSialic Acid Binding Ig-like Lectin 2Time FactorsRetroviridae InfectionsLeukemia, Large Granular LymphocyticNeoplasms, Second PrimaryProto-Oncogene ProteinsJurkat CellsCell SurvivalRadiation-Sensitizing AgentsNeoplasm, ResidualLeukemia, Megakaryoblastic, AcutePreleukemiaAKR murine leukemia virusPrecursor T-Cell Lymphoblastic Leukemia-LymphomaRadiation-Protective AgentsFusion Proteins, bcr-ablLeukemia, Myeloid, Chronic-PhaseLymphocytes